IBYRA 100MG

Ibyra 100mg Tablet belongs to the advanced class of cancer medications known as PARP (poly [adenosine diphosphate-ribose] polymerase inhibitor) inhibitors, containing the active ingredient Olaparib. This medication is specifically used to treat pancreatic and prostate cancer. It can be administered either alone as a single therapy or in combination with other anticancer medications.

It is not recommended to take olaparib if you are allergic to the active compound or any other ingredients of the medicine. You should speak with your doctor immediately if you experience breathlessness, chest pain, a rapid heart rate, fever, cough, or wheezing. Your healthcare provider will conduct essential blood tests before and every month during the treatment, as this medicine could potentially reduce the counts of red blood cells (RBC), white blood cells (WBC), and platelets. Before starting treatment, you must tell your healthcare provider if you have been diagnosed with any problems in your lungs, liver, heart, or kidneys.

It is not advised to use this medication while pregnant, since it may significantly harm the fetus and potentially cause miscarriage. Therefore, for women of reproductive age, it is highly recommended to get a pregnancy test before beginning this medication. It is preferable to continue using effective birth control for at least six months after treatment is finished. While receiving treatment, it is not advised to breastfeed your child, because it is currently unknown if Ibyra 100mg Tablet will find its way into the breast milk. Men are not advised to donate sperm for at least 3 months after the treatment is finished. It is absolutely necessary to inform your doctor about all the medicines you are currently taking, including prescription drugs, over-the-counter medications, vitamins, and other supplements.